{"protocolSection": {"identificationModule": {"nctId": "NCT01651052", "orgStudyIdInfo": {"id": "2010-03"}, "organization": {"fullName": "Edwards Lifesciences", "class": "INDUSTRY"}, "briefTitle": "Clinical Trial of the Edwards Aortic Bioprosthesis, Model 11000", "officialTitle": "Clinical Trial of the Edwards Aortic Bioprosthesis, Model 11000"}, "statusModule": {"statusVerifiedDate": "2019-07", "overallStatus": "COMPLETED", "expandedAccessInfo": {"hasExpandedAccess": false}, "startDateStruct": {"date": "2011-07"}, "primaryCompletionDateStruct": {"date": "2018-07", "type": "ACTUAL"}, "completionDateStruct": {"date": "2018-07", "type": "ACTUAL"}, "studyFirstSubmitDate": "2012-07-18", "studyFirstSubmitQcDate": "2012-07-24", "studyFirstPostDateStruct": {"date": "2012-07-26", "type": "ESTIMATED"}, "resultsFirstSubmitDate": "2019-04-22", "resultsFirstSubmitQcDate": "2019-07-24", "resultsFirstPostDateStruct": {"date": "2019-07-26", "type": "ACTUAL"}, "lastUpdateSubmitDate": "2019-07-24", "lastUpdatePostDateStruct": {"date": "2019-07-26", "type": "ACTUAL"}}, "sponsorCollaboratorsModule": {"responsibleParty": {"type": "SPONSOR"}, "leadSponsor": {"name": "Edwards Lifesciences", "class": "INDUSTRY"}}, "oversightModule": {"oversightHasDmc": true}, "descriptionModule": {"briefSummary": "The purpose of this observational trial is to gather further clinical data to confirm the safety and performance of the Edwards Pericardial Aortic Bioprosthesis, Model 11000 in this trial population.", "detailedDescription": "This is a prospective, non-randomized, non-controlled observational clinical trial. Up to 200 subjects will be enrolled at up to 6 participating clinical sites. The trial will include male and female patients, 18 years or older, requiring replacement for a diseased, damaged, or malfunctioning native or prosthetic valve. Patients will be followed and assessed after implant for up to 5 years."}, "conditionsModule": {"conditions": ["Aortic Valve Disorder", "Aortic Valve Insufficiency", "Aortic Valve Stenosis", "Heart Failure", "Coronary Artery Disease"], "keywords": ["Aortic valve replacement/regurgitation"]}, "designModule": {"studyType": "INTERVENTIONAL", "phases": ["NA"], "designInfo": {"allocation": "NA", "interventionModel": "SINGLE_GROUP", "primaryPurpose": "TREATMENT", "maskingInfo": {"masking": "NONE"}}, "enrollmentInfo": {"count": 133, "type": "ACTUAL"}}, "armsInterventionsModule": {"armGroups": [{"label": "Aortic Bioprosthesis, Model 11000", "type": "EXPERIMENTAL", "description": "Aortic valve replacement therapy", "interventionNames": ["Procedure: Heart Valve Surgery"]}], "interventions": [{"type": "PROCEDURE", "name": "Heart Valve Surgery", "description": "Implant of an aortic valve, Model 11000", "armGroupLabels": ["Aortic Bioprosthesis, Model 11000"]}]}, "outcomesModule": {"primaryOutcomes": [{"measure": "Number of Early Adverse Events Divided by Number of Subjects (Expressed as a Percentage)", "description": "Number of early adverse events occurring within 30 days of procedure divided by the number of enrolled subjects times 100", "timeFrame": "Events occurring within 30 days of procedure"}, {"measure": "Number of Late Adverse Events Divided by Late Patient Years (Expressed as a Percentage)", "description": "Number of late events divided by the total number of late patient years x 100. Late patient years are calculated from 31 days post-implant to the date of the last contact (follow up or adverse event).", "timeFrame": "Events occurring >= 31 days and up through 5 years post-implant"}], "secondaryOutcomes": [{"measure": "Subject's Average Mean Gradient Measurements", "description": "Mean gradient is the average flow of blood through the aortic valve measured in millimeters of mercury. Gradients are evaluated by echocardiography over time. Mean gradient values depend on the size and type of valve.", "timeFrame": "Baseline through 5-Year (at each scheduled follow-up visit)"}, {"measure": "Subject's Average Effective Orifice Area Measurements", "description": "Effective orifice area represents the cross-sectional area of the blood flow downstream of the aortic valve. Effective orifice area is evaluated by echocardiography over time.", "timeFrame": "Baseline through 5-Year (at each scheduled follow-up visit)"}, {"measure": "Subject's New York Heart Association (NYHA) Functional Class Compared to Baseline.", "description": "The New York Heart Association (NYHA) functional classification system relates symptoms to everyday activities and the patient's quality of life.\n\nClass I. Patients with cardiac disease but without resulting limitation of physical activity.\n\nClass II. Patients with cardiac disease resulting in slight limitation of physical activity. They are comfortable at rest.\n\nClass III. Patients with cardiac disease resulting in marked limitation of physical activity. They are comfortable at rest.\n\nClass IV. Patients with cardiac disease resulting in inability to carry on any physical activity without discomfort.\n\nSymptoms of heart failure or the anginal syndrome may be present even at rest.", "timeFrame": "3-6 Months and 1 through 5 Years compared to baseline"}, {"measure": "Subject's Average Score at Baseline and 1 Year on the Quality of Life Survey", "description": "The Medical Outcomes Study Short-Form 12 (SF-12) contains two components - the Physical Component Summary (PCS) and the Mental Component Summary (MCS).\n\nThe SF-12 Physical Component Summary questionnaire scale ranges from a maximum of 100, which reflects the best health status to a minimum of 0, which reflects the worst health status.\n\nThe SF-12 Mental Component Summary scale ranges from a maximum of 100, which reflects the best health status to a minimum of 0, which reflects the worst health status.", "timeFrame": "Baseline and one year follow-up"}, {"measure": "Subject's Average Score on the EQ-5D- Quality of Life Questionnaire Over Time", "description": "The EQ-5D is a standardized questionnaire that asks subjects to rate themselves (no problems, some problems, extreme problems) on mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. The scale is indexed and ranges from a minimum of 0.275 and a maximum of 1.000. A lower number indicates the participants experiences more problems and a higher number indicates the participants experiences fewer problems.", "timeFrame": "Baseline and 1 Year"}], "otherOutcomes": [{"measure": "Subject's Average White Blood Cell Count", "description": "Laboratory analysis of White Blood Cell Count on blood drawn from subject; WBC fight infection.", "timeFrame": "Baseline, 3-6 Months, and 1 through 5 Years"}, {"measure": "Subject's Average Red Blood Cells Count", "description": "Laboratory Analysis of Red Blood Cell Count on blood drawn from subjects; RBC carry oxygen.", "timeFrame": "Baseline, 3-6 Months, and 1 through 5 Years"}, {"measure": "Subject's Average Hemoglobin Count", "description": "Laboratory Analysis of Hemoglobin Count on blood drawn from subjects. Hemoglobin is an oxygen-carrying protein in red blood cells.", "timeFrame": "Baseline, 3-6 months, and 1 through 5 years"}, {"measure": "Subject's Average Hematocrit Percentage", "description": "Laboratory Analysis of Hematocrit Percentage on blood drawn from subjects. Hematocrit is the proportion of red blood cells to the fluid component(plasma) in the blood.", "timeFrame": "Baseline, 3-6 Months, and 1 through 5 Years"}, {"measure": "Subject's Average Platelet Count", "description": "Laboratory Analysis of Platelet Count on blood drawn from subjects; platelets help with blood clotting.", "timeFrame": "Baseline, 3-6 Months, and 1 through 5 Years"}, {"measure": "Subject's Average Plasma Free Hemoglobin", "description": "Laboratory Analysis of Plasma Free Hemoglobin on blood drawn from subjects. This blood test measures the level of free hemoglobin in the liquid part of the blood (the serum).", "timeFrame": "Baseline, 3-6 Months, and 1 through 5 Years"}, {"measure": "Subject's Average Serum Creatinine", "description": "Laboratory Analysis of Serum Creatinine on blood drawn from subjects. Creatinine blood test is a test that measures kidney function.", "timeFrame": "Baseline"}, {"measure": "Subject's Average International Normalized Ratio", "description": "Laboratory Analysis of International Normalized Ratio (INR) on blood drawn from subjects.\n\nThe INR is a calculation based on results of a prothrombin time (PT). The PT is a blood test that measures the time it takes for the liquid portion (plasma) of the blood to clot.", "timeFrame": "Baseline, Discharge, 3-6 Months, 1 Year, 3 Years, and 5 Years"}, {"measure": "Subject's Average Partial Thromboplastin Time", "description": "Laboratory Analysis of partial thromboplastin time (PTT) on blood drawn from subjects. PTT is a blood test that looks at how long it takes for the blood to clot.", "timeFrame": "Baseline, Discharge, 3-6 Months, 1 Year, 3 Years, and 5 Years"}, {"measure": "Subject's Average Prothrombin Time", "description": "Laboratory Analysis of Prothrombin Time (PT) on blood drawn from subjects. The PT is a blood test that measures the time it takes for the liquid portion (plasma) of the blood to clot.", "timeFrame": "Baseline, Discharge, 3-6 Months, 1 Year, 3 Years, and 5 Years"}]}, "eligibilityModule": {"eligibilityCriteria": "Inclusion Criteria:\n\n* 18 years or older\n* Require replacement of aortic valve\n* Signed informed consent\n* Willing to return to study site for follow-up visits\n\nExclusion Criteria:\n\n* Active endocarditis/myocarditis (\\< 3 months)\n* Myocardial infarction (\\< 30 days)\n* Renal insufficiency/ End-stage renal disease\n* Life expectancy (\\< 1 year)\n* Requires multiple valve replacement/repair\n* Requiring emergent aortic valve surgery\n* Pregnant or lactating", "healthyVolunteers": false, "sex": "ALL", "minimumAge": "18 Years", "stdAges": ["ADULT", "OLDER_ADULT"]}, "contactsLocationsModule": {"overallOfficials": [{"name": "Jerzy Sadowski, MD", "affiliation": "John Paul II Hospital", "role": "PRINCIPAL_INVESTIGATOR"}, {"name": "Jacek Rozanski, MD", "affiliation": "The Cardinal Stefan Wyszy\u0144ski Institute of Cardiology", "role": "PRINCIPAL_INVESTIGATOR"}], "locations": [{"facility": "Krakowski Szpital Specjalistyczny im. Jana Paw\u0142a II", "city": "Krak\u00f3w", "zip": "31-202", "country": "Poland", "geoPoint": {"lat": 50.06143, "lon": 19.93658}}, {"facility": "Instytut Kardiologii im. Prymasa Tysi\u0105clecia Stefana Kardyna\u0142a Wyszy\u0144skiego", "city": "Warsaw", "zip": "04-628", "country": "Poland", "geoPoint": {"lat": 52.22977, "lon": 21.01178}}]}, "referencesModule": {"references": [{"pmid": "26182627", "type": "BACKGROUND", "citation": "De La Fuente AB, Wright GA, Olin JM, Duhay FG, Kapelak B, Bochenek M, Bartus K, Sadowski J. Advanced Integrity Preservation Technology Reduces Bioprosthesis Calcification While Preserving Performance and Safety. J Heart Valve Dis. 2015 Jan;24(1):101-9."}, {"pmid": "29297188", "type": "RESULT", "citation": "Bartus K, Litwinowicz R, Kusmierczyk M, Bilewska A, Bochenek M, Stapor M, Wozniak S, Rozanski J, Sadowski J, Kapelak B. Primary safety and effectiveness feasibility study after surgical aortic valve replacement with a new generation bioprosthesis: one-year outcomes. Kardiol Pol. 2018;76(3):618-624. doi: 10.5603/KP.a2017.0262. Epub 2018 Jan 3."}, {"pmid": "25371311", "type": "RESULT", "citation": "Sadowski J, Bartus K, Kapelak B, Chung A, Stapor M, Bochenek M. Aortic valve replacement with a novel anti-calcification technology platform. Kardiol Pol. 2015;73(5):317-22. doi: 10.5603/KP.a2014.0214. Epub 2014 Nov 5."}, {"pmid": "33141188", "type": "DERIVED", "citation": "Bartus K, Litwinowicz R, Bilewska A, Stapor M, Bochenek M, Rozanski J, Sadowski J, Filip G, Kusmierczyk M, Kapelak B. Final 5-year outcomes following aortic valve replacement with a RESILIA tissue bioprosthesis. Eur J Cardiothorac Surg. 2021 Jan 29;59(2):434-441. doi: 10.1093/ejcts/ezaa311."}]}}, "resultsSection": {"participantFlowModule": {"preAssignmentDetails": "133 Subjects were enrolled and implanted with the study valve, for which data is available.", "groups": [{"id": "FG000", "title": "Aortic Bioprosthesis, Model 11000", "description": "Aortic valve replacement therapy\n\nHeart Valve Surgery: Implant of an aortic valve, Model 11000"}], "periods": [{"title": "Overall Study", "milestones": [{"type": "STARTED", "achievements": [{"groupId": "FG000", "numSubjects": "133"}]}, {"type": "Study Valve Group", "achievements": [{"groupId": "FG000", "numSubjects": "133"}]}, {"type": "COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "107"}]}, {"type": "NOT COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "26"}]}], "dropWithdraws": [{"type": "Death", "reasons": [{"groupId": "FG000", "numSubjects": "21"}]}, {"type": "Explant", "reasons": [{"groupId": "FG000", "numSubjects": "1"}]}, {"type": "Withdrawal by Subject", "reasons": [{"groupId": "FG000", "numSubjects": "1"}]}, {"type": "Lost to Follow-up", "reasons": [{"groupId": "FG000", "numSubjects": "3"}]}]}]}, "baselineCharacteristicsModule": {"groups": [{"id": "BG000", "title": "Aortic Bioprosthesis, Model 11000", "description": "Aortic valve replacement therapy\n\nHeart Valve Surgery: Implant of an aortic valve, Model 11000"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "133"}]}], "measures": [{"title": "Age, Continuous", "paramType": "MEAN", "dispersionType": "STANDARD_DEVIATION", "unitOfMeasure": "Years", "classes": [{"categories": [{"measurements": [{"groupId": "BG000", "value": "65.3", "spread": "13.5"}]}]}]}, {"title": "Sex: Female, Male", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"categories": [{"title": "Female", "measurements": [{"groupId": "BG000", "value": "68"}]}, {"title": "Male", "measurements": [{"groupId": "BG000", "value": "65"}]}]}]}, {"title": "Ethnicity (NIH/OMB)", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"categories": [{"title": "Hispanic or Latino", "measurements": [{"groupId": "BG000", "value": "0"}]}, {"title": "Not Hispanic or Latino", "measurements": [{"groupId": "BG000", "value": "113"}]}, {"title": "Unknown or Not Reported", "measurements": [{"groupId": "BG000", "value": "20"}]}]}]}, {"title": "Region of Enrollment", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"title": "Poland", "categories": [{"measurements": [{"groupId": "BG000", "value": "133"}]}]}]}]}, "outcomeMeasuresModule": {"outcomeMeasures": [{"type": "PRIMARY", "title": "Number of Early Adverse Events Divided by Number of Subjects (Expressed as a Percentage)", "description": "Number of early adverse events occurring within 30 days of procedure divided by the number of enrolled subjects times 100", "reportingStatus": "POSTED", "paramType": "NUMBER", "unitOfMeasure": "percentage", "timeFrame": "Events occurring within 30 days of procedure", "groups": [{"id": "OG000", "title": "Aortic Bioprosthesis, Model 11000", "description": "Aortic valve replacement therapy\n\nHeart Valve Surgery: Implant of an aortic valve, Model 11000"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "133"}]}], "classes": [{"title": "All Cause Mortality", "categories": [{"measurements": [{"groupId": "OG000", "value": "2.3"}]}]}, {"title": "Trial valve-related Mortality", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.8"}]}]}, {"title": "Study Valve Related Reoperation", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.0"}]}]}, {"title": "Explant", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.0"}]}]}, {"title": "Thromboembolism", "categories": [{"measurements": [{"groupId": "OG000", "value": "2.3"}]}]}, {"title": "Valve Thrombosis", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.0"}]}]}, {"title": "Bleeding Event", "categories": [{"measurements": [{"groupId": "OG000", "value": "8.3"}]}]}, {"title": "Major Bleeding Event", "categories": [{"measurements": [{"groupId": "OG000", "value": "6.8"}]}]}, {"title": "Paravalvular Leak (PVL)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.8"}]}]}, {"title": "Major Paravalvular Leak", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.0"}]}]}, {"title": "Endocarditis", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.0"}]}]}, {"title": "Hemolysis", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.0"}]}]}, {"title": "Nonstructural Valve Dysfunction (Not PVL)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.0"}]}]}, {"title": "Structural Valve Deterioration", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.0"}]}]}]}, {"type": "PRIMARY", "title": "Number of Late Adverse Events Divided by Late Patient Years (Expressed as a Percentage)", "description": "Number of late events divided by the total number of late patient years x 100. Late patient years are calculated from 31 days post-implant to the date of the last contact (follow up or adverse event).", "reportingStatus": "POSTED", "paramType": "NUMBER", "unitOfMeasure": "Percentage of events/late patient years", "timeFrame": "Events occurring >= 31 days and up through 5 years post-implant", "groups": [{"id": "OG000", "title": "Aortic Bioprosthesis, Model 11000", "description": "Aortic valve replacement therapy\n\nHeart Valve Surgery: Implant of an aortic valve, Model 11000"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "133"}]}], "classes": [{"title": "All Cause Mortality", "categories": [{"measurements": [{"groupId": "OG000", "value": "3.2"}]}]}, {"title": "Trial valve-related mortality", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.7"}]}]}, {"title": "Study Valve Related Reoperation", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.2"}]}]}, {"title": "Explant", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.2"}]}]}, {"title": "Thromboembolism", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.4"}]}]}, {"title": "Valve Thrombosis", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.2"}]}]}, {"title": "Bleeding Event", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.4"}]}]}, {"title": "Major Bleeding Event", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.4"}]}]}, {"title": "Paravalvular Leak (PVL)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.0"}]}]}, {"title": "Major Paravalvular Leak", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.0"}]}]}, {"title": "Endocarditis", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.2"}]}]}, {"title": "Hemolysis", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.0"}]}]}, {"title": "Nonstructural Valve Dysfunction (Not PVL)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.2"}]}]}, {"title": "Structural Valve Deterioration", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.0"}]}]}]}, {"type": "SECONDARY", "title": "Subject's Average Mean Gradient Measurements", "description": "Mean gradient is the average flow of blood through the aortic valve measured in millimeters of mercury. Gradients are evaluated by echocardiography over time. Mean gradient values depend on the size and type of valve.", "populationDescription": "This outcome is reported for subjects who received a Model 11000 surgical aortic heart valve where data is available.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "mmHg", "timeFrame": "Baseline through 5-Year (at each scheduled follow-up visit)", "groups": [{"id": "OG000", "title": "Aortic Bioprosthesis, Model 11000", "description": "Aortic valve replacement therapy\n\nHeart Valve Surgery: Implant of an aortic valve, Model 11000"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "133"}]}], "classes": [{"title": "Baseline", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "133"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "49.4", "spread": "21.7"}]}]}, {"title": "Discharge", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "130"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "12.3", "spread": "5.3"}]}]}, {"title": "3-6 months", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "128"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "12.2", "spread": "5.9"}]}]}, {"title": "1 year", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "119"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "13.9", "spread": "6.1"}]}]}, {"title": "2 year", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "110"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "13.8", "spread": "6.4"}]}]}, {"title": "3 year", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "100"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "14.3", "spread": "6.1"}]}]}, {"title": "4 year", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "98"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "15.0", "spread": "7.2"}]}]}, {"title": "5 year", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "89"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "14.8", "spread": "7.6"}]}]}]}, {"type": "SECONDARY", "title": "Subject's Average Effective Orifice Area Measurements", "description": "Effective orifice area represents the cross-sectional area of the blood flow downstream of the aortic valve. Effective orifice area is evaluated by echocardiography over time.", "populationDescription": "This outcome is reported for subjects who received a Model 11000 surgical aortic heart valve where data is available.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "Centimeters squared", "timeFrame": "Baseline through 5-Year (at each scheduled follow-up visit)", "groups": [{"id": "OG000", "title": "Aortic Bioprosthesis, Model 11000", "description": "Aortic valve replacement therapy\n\nHeart Valve Surgery: Implant of an aortic valve, Model 11000"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "133"}]}], "classes": [{"title": "Baseline", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "130"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "1.0", "spread": "0.8"}]}]}, {"title": "Discharge", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "120"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "2.0", "spread": "0.6"}]}]}, {"title": "3-6 Month", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "126"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "1.8", "spread": "0.5"}]}]}, {"title": "1 Year", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "117"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "1.8", "spread": "0.6"}]}]}, {"title": "2 Year", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "108"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "1.6", "spread": "0.5"}]}]}, {"title": "3 Year", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "100"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "1.5", "spread": "0.5"}]}]}, {"title": "4 Year", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "81"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "1.5", "spread": "0.4"}]}]}, {"title": "5 Year", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "89"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "1.4", "spread": "0.5"}]}]}]}, {"type": "SECONDARY", "title": "Subject's New York Heart Association (NYHA) Functional Class Compared to Baseline.", "description": "The New York Heart Association (NYHA) functional classification system relates symptoms to everyday activities and the patient's quality of life.\n\nClass I. Patients with cardiac disease but without resulting limitation of physical activity.\n\nClass II. Patients with cardiac disease resulting in slight limitation of physical activity. They are comfortable at rest.\n\nClass III. Patients with cardiac disease resulting in marked limitation of physical activity. They are comfortable at rest.\n\nClass IV. Patients with cardiac disease resulting in inability to carry on any physical activity without discomfort.\n\nSymptoms of heart failure or the anginal syndrome may be present even at rest.", "populationDescription": "This outcome is reported for subjects who received the Model 11000 surgical aortic heart valve where data is available.", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "3-6 Months and 1 through 5 Years compared to baseline", "groups": [{"id": "OG000", "title": "Aortic Bioprosthesis, Model 11000", "description": "Aortic valve replacement therapy\n\nHeart Valve Surgery: Implant of an aortic valve, Model 11000"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "133"}]}], "classes": [{"title": "Improve at 3-6 Months", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "128"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "89"}]}]}, {"title": "Same at 3-6 Months", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "128"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "36"}]}]}, {"title": "Worse at 3-6 months", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "128"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "3"}]}]}, {"title": "Improve at 1 Year", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "122"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "68"}]}]}, {"title": "Same at 1 Year", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "122"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "48"}]}]}, {"title": "Worse at 1 Year", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "122"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "6"}]}]}, {"title": "Improve at 2 Years", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "111"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "68"}]}]}, {"title": "Same at 2 Years", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "111"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "34"}]}]}, {"title": "Worse at 2 Years", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "111"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "9"}]}]}, {"title": "Improve at 3 Years", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "105"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "59"}]}]}, {"title": "Same at 3 Years", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "105"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "41"}]}]}, {"title": "Worse at 3 Years", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "105"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "5"}]}]}, {"title": "Improve at 4 Years", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "101"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "55"}]}]}, {"title": "Same at 4 Years", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "101"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "40"}]}]}, {"title": "Worse at 4 Years", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "101"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "6"}]}]}, {"title": "Improve at 5 Years", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "91"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "50"}]}]}, {"title": "Same at 5 Years", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "91"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "33"}]}]}, {"title": "Worse at 5 Years", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "91"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "8"}]}]}]}, {"type": "SECONDARY", "title": "Subject's Average Score at Baseline and 1 Year on the Quality of Life Survey", "description": "The Medical Outcomes Study Short-Form 12 (SF-12) contains two components - the Physical Component Summary (PCS) and the Mental Component Summary (MCS).\n\nThe SF-12 Physical Component Summary questionnaire scale ranges from a maximum of 100, which reflects the best health status to a minimum of 0, which reflects the worst health status.\n\nThe SF-12 Mental Component Summary scale ranges from a maximum of 100, which reflects the best health status to a minimum of 0, which reflects the worst health status.", "populationDescription": "This outcome is reported for subjects who received a Model 11000 surgical aortic heart valve where data is available.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "units on a scale", "timeFrame": "Baseline and one year follow-up", "groups": [{"id": "OG000", "title": "Aortic Bioprosthesis, Model 11000", "description": "Aortic valve replacement therapy\n\nHeart Valve Surgery: Implant of an aortic valve, Model 11000"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "56"}]}], "classes": [{"title": "Physical Health - Baseline", "categories": [{"measurements": [{"groupId": "OG000", "value": "42.5", "spread": "10.2"}]}]}, {"title": "Physical Health - 1 Year follow-up", "categories": [{"measurements": [{"groupId": "OG000", "value": "49", "spread": "7.4"}]}]}, {"title": "Mental Health - Baseline", "categories": [{"measurements": [{"groupId": "OG000", "value": "50.2", "spread": "8.6"}]}]}, {"title": "Mental Health - 1 Year follow-up", "categories": [{"measurements": [{"groupId": "OG000", "value": "51.2", "spread": "7.3"}]}]}]}, {"type": "SECONDARY", "title": "Subject's Average Score on the EQ-5D- Quality of Life Questionnaire Over Time", "description": "The EQ-5D is a standardized questionnaire that asks subjects to rate themselves (no problems, some problems, extreme problems) on mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. The scale is indexed and ranges from a minimum of 0.275 and a maximum of 1.000. A lower number indicates the participants experiences more problems and a higher number indicates the participants experiences fewer problems.", "populationDescription": "This outcome is reported for subjects who received a Model 11000 surgical aortic heart valve where data is available.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "units on a scale", "timeFrame": "Baseline and 1 Year", "groups": [{"id": "OG000", "title": "Aortic Bioprosthesis, Model 11000", "description": "Aortic valve replacement therapy\n\nHeart Valve Surgery: Implant of an aortic valve, Model 11000"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "56"}]}], "classes": [{"title": "Baseline", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.81", "spread": "0.20"}]}]}, {"title": "1 Year follow-up", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.87", "spread": "0.20"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Subject's Average White Blood Cell Count", "description": "Laboratory analysis of White Blood Cell Count on blood drawn from subject; WBC fight infection.", "populationDescription": "This outcome is reported for subjects who received a Model 11000 surgical aortic heart valve where data is available.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "10^3 cells/microliters", "timeFrame": "Baseline, 3-6 Months, and 1 through 5 Years", "groups": [{"id": "OG000", "title": "Aortic Bioprosthesis, Model 11000", "description": "Aortic valve replacement therapy\n\nHeart Valve Surgery: Implant of an aortic valve, Model 11000"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "133"}]}], "classes": [{"title": "Baseline", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "133"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "7.0", "spread": "1.7"}]}]}, {"title": "3-6 Months", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "124"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "7.5", "spread": "2.2"}]}]}, {"title": "1 Year", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "106"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "7.3", "spread": "1.8"}]}]}, {"title": "2 Year", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "108"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "7.2", "spread": "1.6"}]}]}, {"title": "3 Year", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "95"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "7.1", "spread": "1.8"}]}]}, {"title": "4 Year", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "80"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "7.2", "spread": "1.8"}]}]}, {"title": "5 Year", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "70"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "7.2", "spread": "1.9"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Subject's Average Red Blood Cells Count", "description": "Laboratory Analysis of Red Blood Cell Count on blood drawn from subjects; RBC carry oxygen.", "populationDescription": "This outcome is reported for subjects who received a Model 11000 surgical aortic heart valve where data is available.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "10^6 cells/microliters", "timeFrame": "Baseline, 3-6 Months, and 1 through 5 Years", "groups": [{"id": "OG000", "title": "Aortic Bioprosthesis, Model 11000", "description": "Aortic valve replacement therapy\n\nHeart Valve Surgery: Implant of an aortic valve, Model 11000"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "133"}]}], "classes": [{"title": "Baseline", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "133"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "4.5", "spread": "0.5"}]}]}, {"title": "3-6 Months", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "124"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "4.7", "spread": "0.5"}]}]}, {"title": "1 Year", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "106"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "4.6", "spread": "0.4"}]}]}, {"title": "2 Year", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "108"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "4.6", "spread": "0.5"}]}]}, {"title": "3 Year", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "95"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "4.7", "spread": "0.5"}]}]}, {"title": "4 Year", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "80"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "4.6", "spread": "0.5"}]}]}, {"title": "5 Year", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "70"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "4.6", "spread": "0.5"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Subject's Average Hemoglobin Count", "description": "Laboratory Analysis of Hemoglobin Count on blood drawn from subjects. Hemoglobin is an oxygen-carrying protein in red blood cells.", "populationDescription": "This outcome is reported for subjects who received a Model 11000 surgical aortic heart valve where data is available.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "g/dl", "timeFrame": "Baseline, 3-6 months, and 1 through 5 years", "groups": [{"id": "OG000", "title": "Aortic Bioprosthesis, Model 11000", "description": "Aortic valve replacement therapy\n\nHeart Valve Surgery: Implant of an aortic valve, Model 11000"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "133"}]}], "classes": [{"title": "Baseline", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "133"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "13.5", "spread": "1.5"}]}]}, {"title": "3-6 Months", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "124"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "13.3", "spread": "1.4"}]}]}, {"title": "1 Year", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "107"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "13.7", "spread": "1.4"}]}]}, {"title": "2 Years", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "108"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "13.8", "spread": "1.5"}]}]}, {"title": "3 Years", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "95"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "14.0", "spread": "1.3"}]}]}, {"title": "4 Years", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "80"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "13.9", "spread": "1.6"}]}]}, {"title": "5 Years", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "70"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "13.7", "spread": "1.5"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Subject's Average Hematocrit Percentage", "description": "Laboratory Analysis of Hematocrit Percentage on blood drawn from subjects. Hematocrit is the proportion of red blood cells to the fluid component(plasma) in the blood.", "populationDescription": "This outcome is reported for subjects who received a Model 11000 surgical aortic heart valve where data is available.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "percentage of red blood cells", "timeFrame": "Baseline, 3-6 Months, and 1 through 5 Years", "groups": [{"id": "OG000", "title": "Aortic Bioprosthesis, Model 11000", "description": "Aortic valve replacement therapy\n\nHeart Valve Surgery: Implant of an aortic valve, Model 11000"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "133"}]}], "classes": [{"title": "Baseline", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "133"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "40.1", "spread": "4.2"}]}]}, {"title": "3-6 Months", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "124"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "40.5", "spread": "3.8"}]}]}, {"title": "1 Year", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "106"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "40.7", "spread": "3.5"}]}]}, {"title": "2 Years", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "108"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "41.1", "spread": "3.7"}]}]}, {"title": "3 Years", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "95"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "41.9", "spread": "3.6"}]}]}, {"title": "4 Years", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "80"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "41.9", "spread": "7.0"}]}]}, {"title": "5 Years", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "70"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "41.4", "spread": "4.0"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Subject's Average Platelet Count", "description": "Laboratory Analysis of Platelet Count on blood drawn from subjects; platelets help with blood clotting.", "populationDescription": "This outcome is reported for subjects who received a Model 11000 surgical aortic heart valve where data is available.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "10^3 platelets per microliter", "timeFrame": "Baseline, 3-6 Months, and 1 through 5 Years", "groups": [{"id": "OG000", "title": "Aortic Bioprosthesis, Model 11000", "description": "Aortic valve replacement therapy\n\nHeart Valve Surgery: Implant of an aortic valve, Model 11000"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "133"}]}], "classes": [{"title": "Baseline", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "133"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "196.0", "spread": "48.3"}]}]}, {"title": "3-6 Months", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "124"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "203.1", "spread": "55.9"}]}]}, {"title": "1 Year", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "106"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "196.6", "spread": "49.8"}]}]}, {"title": "2 Years", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "108"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "195.8", "spread": "47.1"}]}]}, {"title": "3 Years", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "95"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "188.7", "spread": "45.4"}]}]}, {"title": "4 Years", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "80"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "194.4", "spread": "54.8"}]}]}, {"title": "5 Years", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "70"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "206.6", "spread": "57.7"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Subject's Average Plasma Free Hemoglobin", "description": "Laboratory Analysis of Plasma Free Hemoglobin on blood drawn from subjects. This blood test measures the level of free hemoglobin in the liquid part of the blood (the serum).", "populationDescription": "This outcome is reported for subjects who received a Model 11000 surgical aortic heart valve where data is available.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "mg/dl", "timeFrame": "Baseline, 3-6 Months, and 1 through 5 Years", "groups": [{"id": "OG000", "title": "Aortic Bioprosthesis, Model 11000", "description": "Aortic valve replacement therapy\n\nHeart Valve Surgery: Implant of an aortic valve, Model 11000"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "133"}]}], "classes": [{"title": "Baseline", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "51"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "12.9", "spread": "13.9"}]}]}, {"title": "3-6 Years", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "101"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "12.1", "spread": "8.1"}]}]}, {"title": "1 Year", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "75"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "14.2", "spread": "24.6"}]}]}, {"title": "2 Years", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "108"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "18.6", "spread": "27.7"}]}]}, {"title": "3 Years", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "97"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "19.3", "spread": "25.7"}]}]}, {"title": "4 Years", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "75"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "20.1", "spread": "26.6"}]}]}, {"title": "5 Years", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "70"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "28.1", "spread": "38.5"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Subject's Average Serum Creatinine", "description": "Laboratory Analysis of Serum Creatinine on blood drawn from subjects. Creatinine blood test is a test that measures kidney function.", "populationDescription": "This outcome is reported for subjects who received a Model 11000 surgical aortic heart valve where data is available.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "micromol/l", "timeFrame": "Baseline", "groups": [{"id": "OG000", "title": "Aortic Bioprosthesis, Model 11000", "description": "Aortic valve replacement therapy\n\nHeart Valve Surgery: Implant of an aortic valve, Model 11000"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "53"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "84.0", "spread": "17.4"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Subject's Average International Normalized Ratio", "description": "Laboratory Analysis of International Normalized Ratio (INR) on blood drawn from subjects.\n\nThe INR is a calculation based on results of a prothrombin time (PT). The PT is a blood test that measures the time it takes for the liquid portion (plasma) of the blood to clot.", "populationDescription": "This outcome is reported for subjects who received a Model 11000 surgical aortic heart valve where data is available.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "Ratio", "timeFrame": "Baseline, Discharge, 3-6 Months, 1 Year, 3 Years, and 5 Years", "groups": [{"id": "OG000", "title": "Aortic Bioprosthesis, Model 11000", "description": "Aortic valve replacement therapy\n\nHeart Valve Surgery: Implant of an aortic valve, Model 11000"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "133"}]}], "classes": [{"title": "Baseline", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "133"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "1.0", "spread": "0.1"}]}]}, {"title": "Discharge", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "112"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "1.9", "spread": "1.0"}]}]}, {"title": "3-6 Months", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "123"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "1.9", "spread": "0.8"}]}]}, {"title": "1 Year", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "106"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "1.2", "spread": "0.5"}]}]}, {"title": "3 Years", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "96"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "1.2", "spread": "0.6"}]}]}, {"title": "5 Years", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "69"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "1.2", "spread": "0.6"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Subject's Average Partial Thromboplastin Time", "description": "Laboratory Analysis of partial thromboplastin time (PTT) on blood drawn from subjects. PTT is a blood test that looks at how long it takes for the blood to clot.", "populationDescription": "This outcome is reported for subjects who received a Model 11000 surgical aortic heart valve where data is available.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "Seconds", "timeFrame": "Baseline, Discharge, 3-6 Months, 1 Year, 3 Years, and 5 Years", "groups": [{"id": "OG000", "title": "Aortic Bioprosthesis, Model 11000", "description": "Aortic valve replacement therapy\n\nHeart Valve Surgery: Implant of an aortic valve, Model 11000"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "133"}]}], "classes": [{"title": "Baseline", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "132"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "30.0", "spread": "6.5"}]}]}, {"title": "Discharge", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "108"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "39.5", "spread": "10.5"}]}]}, {"title": "3-6 Months", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "121"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "35.1", "spread": "8.9"}]}]}, {"title": "1 Year", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "106"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "28.6", "spread": "5.2"}]}]}, {"title": "3 Years", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "94"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "29.9", "spread": "10.2"}]}]}, {"title": "5 Years", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "69"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "33.6", "spread": "10.2"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Subject's Average Prothrombin Time", "description": "Laboratory Analysis of Prothrombin Time (PT) on blood drawn from subjects. The PT is a blood test that measures the time it takes for the liquid portion (plasma) of the blood to clot.", "populationDescription": "This outcome is reported for subjects who received a Model 11000 surgical aortic heart valve where data is available.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "Seconds", "timeFrame": "Baseline, Discharge, 3-6 Months, 1 Year, 3 Years, and 5 Years", "groups": [{"id": "OG000", "title": "Aortic Bioprosthesis, Model 11000", "description": "Aortic valve replacement therapy\n\nHeart Valve Surgery: Implant of an aortic valve, Model 11000"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "133"}]}], "classes": [{"title": "Baseline", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "113"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "11.9", "spread": "1.9"}]}]}, {"title": "Discharge", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "112"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "21.5", "spread": "11.5"}]}]}, {"title": "3-6 Months", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "104"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "19.4", "spread": "9.1"}]}]}, {"title": "1 Year", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "88"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "14.0", "spread": "5.9"}]}]}, {"title": "3 Years", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "79"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "13.4", "spread": "5.3"}]}]}, {"title": "5 Years", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "58"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "12.5", "spread": "4.3"}]}]}]}]}, "adverseEventsModule": {"frequencyThreshold": "0", "timeFrame": "Events occurring from baseline through five years post implant", "eventGroups": [{"id": "EG000", "title": "Aortic Bioprosthesis, Model 11000", "description": "Aortic valve replacement therapy\n\nHeart Valve Surgery: Implant of an aortic valve, Model 11000", "deathsNumAffected": 21, "deathsNumAtRisk": 133, "seriousNumAffected": 74, "seriousNumAtRisk": 133, "otherNumAffected": 41, "otherNumAtRisk": 133}], "seriousEvents": [{"term": "Anemia - non-bleeding related", "organSystem": "Blood and lymphatic system disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 133}]}, {"term": "Angina, stable", "organSystem": "Cardiac disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 133}]}, {"term": "Arrhythmia-AV block III", "organSystem": "Cardiac disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 133}]}, {"term": "Arrhythmia - AV block - 3rd degree", "organSystem": "Cardiac disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 3, "numAffected": 3, "numAtRisk": 133}]}, {"term": "Arrhythmia - bradycardia", "organSystem": "Cardiac disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 133}]}, {"term": "Arrhythmia - paroxysmal atrial fibrillation (PAF)", "organSystem": "Cardiac disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 9, "numAffected": 7, "numAtRisk": 133}]}, {"term": "Arrhythmia - persistent atrial fibrillation", "organSystem": "Cardiac disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 4, "numAffected": 3, "numAtRisk": 133}]}, {"term": "Arrhythmia - supraventricular tachycardia (SVT)", "organSystem": "Cardiac disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 133}]}, {"term": "Arrhythmia - tachy-bradycardia", "organSystem": "Cardiac disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 133}]}, {"term": "Arrhythmia - ventricular fibrillation", "organSystem": "Cardiac disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 133}]}, {"term": "Biliary (gallbladder)", "organSystem": "Gastrointestinal disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 4, "numAffected": 3, "numAtRisk": 133}]}, {"term": "Bleeding event", "organSystem": "Blood and lymphatic system disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 12, "numAffected": 12, "numAtRisk": 133}]}, {"term": "Bone fracture/break", "organSystem": "Musculoskeletal and connective tissue disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 3, "numAffected": 3, "numAtRisk": 133}]}, {"term": "Cancer - newly diagnosed", "organSystem": "General disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 6, "numAffected": 6, "numAtRisk": 133}]}, {"term": "Cancer - progression of underlying disease", "organSystem": "General disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 5, "numAffected": 2, "numAtRisk": 133}]}, {"term": "Cardiac arrest", "organSystem": "Cardiac disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 3, "numAffected": 3, "numAtRisk": 133}]}, {"term": "Cardiac decompensation", "organSystem": "Cardiac disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 4, "numAffected": 4, "numAtRisk": 133}]}, {"term": "Cardiovascular - other", "organSystem": "Cardiac disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 133}]}, {"term": "Cardiovascular - other --> infection inflammation", "organSystem": "Cardiac disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 133}]}, {"term": "Endocarditis", "organSystem": "Cardiac disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 133}]}, {"term": "Endocrine complications", "organSystem": "Endocrine disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 133}]}, {"term": "Gastrointestinal - other", "organSystem": "Gastrointestinal disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 6, "numAffected": 5, "numAtRisk": 133}]}, {"term": "Genitourinary - other", "organSystem": "Renal and urinary disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 3, "numAffected": 2, "numAtRisk": 133}]}, {"term": "Heart failure - chronic (CHF)", "organSystem": "Cardiac disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 133}]}, {"term": "Hypertension - systemic", "organSystem": "Cardiac disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 133}]}, {"term": "Muscular skeletal / dermatologic - other", "organSystem": "Musculoskeletal and connective tissue disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 6, "numAffected": 5, "numAtRisk": 133}]}, {"term": "Myocardial infarction", "organSystem": "Cardiac disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 133}]}, {"term": "Nonspecific, unknown or other body system - other complication", "organSystem": "General disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 5, "numAffected": 4, "numAtRisk": 133}]}, {"term": "Pancreatic complication", "organSystem": "Gastrointestinal disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 133}]}, {"term": "Pericardial effusion", "organSystem": "Cardiac disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 133}]}, {"term": "Pericardial effusion - major", "organSystem": "Cardiac disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 4, "numAffected": 4, "numAtRisk": 133}]}, {"term": "Pericardial effusion - minor", "organSystem": "Cardiac disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 133}]}, {"term": "Pericardial tamponade - major", "organSystem": "Cardiac disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 3, "numAffected": 3, "numAtRisk": 133}]}, {"term": "Pleural effusion - bilateral", "organSystem": "Respiratory, thoracic and mediastinal disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 133}]}, {"term": "Pleural effusion - left", "organSystem": "Respiratory, thoracic and mediastinal disorders", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 3, "numAffected": 3, "numAtRisk": 133}]}, {"term": "Pleural effusion - right", "organSystem": "Respiratory, thoracic and mediastinal disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 133}]}, {"term": "Pneumothorax", "organSystem": "Respiratory, thoracic and mediastinal disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 133}]}, {"term": "Pulmonary/respiratory - other", "organSystem": "Respiratory, thoracic and mediastinal disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 133}]}, {"term": "Renal - other", "organSystem": "Renal and urinary disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 3, "numAffected": 3, "numAtRisk": 133}]}, {"term": "Renal dysfunction", "organSystem": "Renal and urinary disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 133}]}, {"term": "Renal failure - acute", "organSystem": "Renal and urinary disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 133}]}, {"term": "Renal failure - chronic", "organSystem": "Renal and urinary disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 133}]}, {"term": "Respiratory dysfunction/insufficiency", "organSystem": "Respiratory, thoracic and mediastinal disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 133}]}, {"term": "Respiratory failure - pneumonia", "organSystem": "Respiratory, thoracic and mediastinal disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 133}]}, {"term": "Respiratory infection - pneumonia", "organSystem": "Respiratory, thoracic and mediastinal disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 133}]}, {"term": "Respiratory infection - upper", "organSystem": "Respiratory, thoracic and mediastinal disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 3, "numAffected": 3, "numAtRisk": 133}]}, {"term": "Sternal wound/thoracic infection", "organSystem": "Musculoskeletal and connective tissue disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 4, "numAffected": 4, "numAtRisk": 133}]}, {"term": "Sudden death", "organSystem": "General disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 133}]}, {"term": "Tachy-bradycardia", "organSystem": "Cardiac disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 133}]}, {"term": "Thromboembolism", "organSystem": "Cardiac disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 5, "numAffected": 5, "numAtRisk": 133}]}, {"term": "Transient psychotic syndrome", "organSystem": "Psychiatric disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 133}]}, {"term": "Valve thrombosis", "organSystem": "Cardiac disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 133}]}, {"term": "Vascular - other", "organSystem": "Vascular disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 3, "numAffected": 3, "numAtRisk": 133}]}, {"term": "Vision disorder", "organSystem": "Eye disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 133}]}, {"term": "Wound infection - other", "organSystem": "Infections and infestations", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 133}]}], "otherEvents": [{"term": "Arrhythmia - AV block - 1st degree", "organSystem": "Cardiac disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 133}]}, {"term": "Arrhythmia - paroxysmal atrial fibrillation (PAF)", "organSystem": "Cardiac disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 18, "numAffected": 18, "numAtRisk": 133}]}, {"term": "Arrhythmia - paroxysmal atrial tachycardia (PAT)", "organSystem": "Cardiac disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 133}]}, {"term": "Arrhythmia - permanent atrial fibrillation", "organSystem": "Cardiac disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 133}]}, {"term": "Arrhythmia - persistent atrial fibrillation", "organSystem": "Cardiac disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 4, "numAffected": 4, "numAtRisk": 133}]}, {"term": "Arrhythmia - tachy-bradycardia", "organSystem": "Cardiac disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 133}]}, {"term": "Bleeding event", "organSystem": "Blood and lymphatic system disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 133}]}, {"term": "Cardiovascular - other", "organSystem": "Cardiac disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 133}]}, {"term": "Non structural valve dysfunction", "organSystem": "Cardiac disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 133}]}, {"term": "Nonspecific, unknown or other body system - other complication", "organSystem": "General disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 133}]}, {"term": "Pericardial effusion - minor", "organSystem": "Cardiac disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 133}]}, {"term": "Pleural effusion - right", "organSystem": "Respiratory, thoracic and mediastinal disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 133}]}, {"term": "Pneumothorax", "organSystem": "Respiratory, thoracic and mediastinal disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 3, "numAffected": 3, "numAtRisk": 133}]}, {"term": "Renal dysfunction", "organSystem": "Renal and urinary disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 133}]}, {"term": "Respiratory infection - upper", "organSystem": "Respiratory, thoracic and mediastinal disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 133}]}, {"term": "Stenosis - tricuspid - moderate", "organSystem": "Cardiac disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 133}]}, {"term": "Transient psychotic syndrome", "organSystem": "Psychiatric disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 3, "numAffected": 3, "numAtRisk": 133}]}, {"term": "Vision disorder", "organSystem": "Eye disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 4, "numAffected": 4, "numAtRisk": 133}]}]}, "moreInfoModule": {"certainAgreement": {"piSponsorEmployee": false, "restrictionType": "OTHER", "restrictiveAgreement": true, "otherDetails": "PI can't publish/present on overall study results not yet published but may publish his own data subject to EW review prior to submission/presentation, but data analyses of site-specific results can occur only in intervals as specified in the CTA. Publication/presentation of the PI's site-specific results of devices which haven't been market released and which still may be undergoing development, shall not include claims of device safety/effectiveness and will require the review/approval of EW."}, "pointOfContact": {"title": "Mary Edwards, VP Clinical and Regulatory Affairs, Surgical Structural Heart", "organization": "Edwards Lifesciences, LLC", "email": "mary_edwards@edwards.com", "phone": "949-250-2500", "phoneExt": "1536"}}}, "documentSection": {"largeDocumentModule": {"largeDocs": [{"typeAbbrev": "Prot_SAP", "hasProtocol": true, "hasSap": true, "hasIcf": false, "label": "Study Protocol and Statistical Analysis Plan", "date": "2012-05-08", "uploadDate": "2019-04-12T18:45", "filename": "Prot_SAP_000.pdf", "size": 18798415}]}}, "derivedSection": {"miscInfoModule": {"versionHolder": "2024-06-24"}, "conditionBrowseModule": {"meshes": [{"id": "D000003324", "term": "Coronary Artery Disease"}, {"id": "D000001024", "term": "Aortic Valve Stenosis"}, {"id": "D000001022", "term": "Aortic Valve Insufficiency"}, {"id": "D000082862", "term": "Aortic Valve Disease"}], "ancestors": [{"id": "D000006331", "term": "Heart Diseases"}, {"id": "D000002318", "term": "Cardiovascular Diseases"}, {"id": "D000003327", "term": "Coronary Disease"}, {"id": "D000017202", "term": "Myocardial Ischemia"}, {"id": "D000001161", "term": "Arteriosclerosis"}, {"id": "D000001157", "term": "Arterial Occlusive Diseases"}, {"id": "D000014652", "term": "Vascular Diseases"}, {"id": "D000006349", "term": "Heart Valve Diseases"}, {"id": "D000014694", "term": "Ventricular Outflow Obstruction"}], "browseLeaves": [{"id": "M6546", "name": "Coronary Artery Disease", "asFound": "Coronary Artery Disease", "relevance": "HIGH"}, {"id": "M6475", "name": "Constriction, Pathologic", "relevance": "LOW"}, {"id": "M4340", "name": "Aortic Valve Stenosis", "asFound": "Aortic Valve Stenosis", "relevance": "HIGH"}, {"id": "M9421", "name": "Heart Failure", "relevance": "LOW"}, {"id": "M19506", "name": "Myocardial Ischemia", "relevance": "LOW"}, {"id": "M6549", "name": "Coronary Disease", "relevance": "LOW"}, {"id": "M2379", "name": "Aortic Valve Disease", "asFound": "Aortic Valve Disorder", "relevance": "HIGH"}, {"id": "M4338", "name": "Aortic Valve Insufficiency", "asFound": "Aortic Valve Insufficiency", "relevance": "HIGH"}, {"id": "M9419", "name": "Heart Diseases", "relevance": "LOW"}, {"id": "M10543", "name": "Ischemia", "relevance": "LOW"}, {"id": "M4469", "name": "Arteriosclerosis", "relevance": "LOW"}, {"id": "M4465", "name": "Arterial Occlusive Diseases", "relevance": "LOW"}, {"id": "M17400", "name": "Vascular Diseases", "relevance": "LOW"}, {"id": "M9437", "name": "Heart Valve Diseases", "relevance": "LOW"}, {"id": "M17440", "name": "Ventricular Outflow Obstruction", "relevance": "LOW"}, {"id": "T449", "name": "Aortic Valve Stenosis", "asFound": "Aortic Valve Stenosis", "relevance": "HIGH"}], "browseBranches": [{"abbrev": "BC14", "name": "Heart and Blood Diseases"}, {"abbrev": "All", "name": "All Conditions"}, {"abbrev": "BC23", "name": "Symptoms and General Pathology"}, {"abbrev": "Rare", "name": "Rare Diseases"}]}}, "hasResults": true}